ZITHROMAC SR

Zithromac Sr Adverse Events Reported to the FDA Over Time

How are Zithromac Sr adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zithromac Sr is flagged as the suspect drug causing the adverse event.

Most Common Zithromac Sr Adverse Events Reported to the FDA

What are the most common Zithromac Sr adverse events reported to the FDA?

Diarrhoea	29 (6.95%)
Abdominal Pain	13 (3.12%)
Loss Of Consciousness	13 (3.12%)
Rhabdomyolysis	12 (2.88%)
Nausea	9 (2.16%)
Pneumonia	9 (2.16%)
Vomiting	9 (2.16%)
Altered State Of Consciousness	8 (1.92%)
Chest Discomfort	8 (1.92%)
Oedema	8 (1.92%)
Hypoaesthesia	7 (1.68%)
	Show More
Hypothermia	7 (1.68%)
Myalgia	7 (1.68%)
Shock	7 (1.68%)
Haematuria	6 (1.44%)
Hepatic Function Abnormal	6 (1.44%)
Malaise	6 (1.44%)
Pyrexia	6 (1.44%)
Arthralgia	5 (1.2%)
Chills	5 (1.2%)
Feeling Abnormal	5 (1.2%)
Platelet Count Increased	5 (1.2%)
Renal Failure Acute	5 (1.2%)
Alanine Aminotransferase Increased	4 (.96%)
Anaphylactic Shock	4 (.96%)
Aspartate Aminotransferase Increase...	4 (.96%)
Asthenia	4 (.96%)
Blast Cell Crisis	4 (.96%)
Cardiac Failure	4 (.96%)
Dyspnoea	4 (.96%)
Eosinophilic Pneumonia	4 (.96%)
Hyperglycaemia	4 (.96%)
Interstitial Lung Disease	4 (.96%)
Tremor	4 (.96%)
Arthritis	3 (.72%)
Blood Bilirubin Increased	3 (.72%)
Blood Creatine Phosphokinase Increa...	3 (.72%)
Cardiac Arrest	3 (.72%)
Cardiac Failure Acute	3 (.72%)
Cholangitis	3 (.72%)
Colitis Ischaemic	3 (.72%)
Decreased Appetite	3 (.72%)
Depressed Level Of Consciousness	3 (.72%)
Dizziness	3 (.72%)
Dysgeusia	3 (.72%)
Enterocolitis Haemorrhagic	3 (.72%)
Gastroenteritis	3 (.72%)
Gastrointestinal Inflammation	3 (.72%)
Granulocytopenia	3 (.72%)
Haematochezia	3 (.72%)
Hypoaesthesia Facial	3 (.72%)
Mallory-weiss Syndrome	3 (.72%)
Palpitations	3 (.72%)
Peripheral Coldness	3 (.72%)
Abdominal Pain Upper	2 (.48%)
Anti-neutrophil Cytoplasmic Antibod...	2 (.48%)
Asphyxia	2 (.48%)
Blood Pressure Decreased	2 (.48%)
Body Temperature Decreased	2 (.48%)
Death	2 (.48%)
Dehydration	2 (.48%)
Diarrhoea Haemorrhagic	2 (.48%)
Drug Ineffective	2 (.48%)
Drug Interaction	2 (.48%)
Dysarthria	2 (.48%)
Face Oedema	2 (.48%)
Flank Pain	2 (.48%)
Gastric Ulcer Haemorrhage	2 (.48%)
Gastroenteritis Eosinophilic	2 (.48%)
Inappropriate Antidiuretic Hormone ...	2 (.48%)
International Normalised Ratio Incr...	2 (.48%)
Jaundice	2 (.48%)
Liver Disorder	2 (.48%)
Melaena	2 (.48%)
Mouth Ulceration	2 (.48%)
Musculoskeletal Stiffness	2 (.48%)
Oculomucocutaneous Syndrome	2 (.48%)
Paraesthesia	2 (.48%)
Pseudodementia	2 (.48%)
Rash	2 (.48%)
Syncope	2 (.48%)
Therapeutic Agent Toxicity	2 (.48%)
Urinary Tract Infection	2 (.48%)
Vaginal Haemorrhage	2 (.48%)
White Blood Cell Count Decreased	2 (.48%)
Abdominal Discomfort	1 (.24%)
Abnormal Behaviour	1 (.24%)
Adverse Drug Reaction	1 (.24%)
Aphthous Stomatitis	1 (.24%)
Blood Alkaline Phosphatase Increase...	1 (.24%)
Blood Glucose Increased	1 (.24%)
Bronchopneumonia	1 (.24%)
C-reactive Protein Increased	1 (.24%)
Cardioactive Drug Level Increased	1 (.24%)
Cerebrovascular Accident	1 (.24%)
Cheilitis	1 (.24%)
Cold Sweat	1 (.24%)
Contusion	1 (.24%)
Daydreaming	1 (.24%)
Diabetes Mellitus Inadequate Contro...	1 (.24%)
Disorientation	1 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac Sr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zithromac Sr

What are the most common Zithromac Sr adverse events reported to the FDA?

Neurological	46 (11.03%)
Gastrointestinal Signs	36 (8.63%)
Gastrointestinal Motility And Defec...	31 (7.43%)
Muscle	20 (4.8%)
Infections - Pathogen Unspecified	15 (3.6%)
Body Temperature Conditions	13 (3.12%)
Hepatobiliary	13 (3.12%)
Gastrointestinal Inflammatory Condi...	12 (2.88%)
Hepatic And Hepatobiliary	11 (2.64%)
Hematology Investigations	10 (2.4%)
Epidermal And Dermal Conditions	9 (2.16%)
	Show More
Lower Respiratory Tract Disorders	9 (2.16%)
Respiratory	9 (2.16%)
Decreased And Nonspecific Blood Pre...	8 (1.92%)
Gastrointestinal Hemorrhages	8 (1.92%)
Joint	8 (1.92%)
Heart Failures	7 (1.68%)
Glucose Metabolism Disorders	6 (1.44%)
Oral Soft Tissue Conditions	6 (1.44%)
Renal Disorders	6 (1.44%)
Urinary Tract Signs	6 (1.44%)
Allergic Conditions	5 (1.2%)
Musculoskeletal And Connective Tiss...	5 (1.2%)
Therapeutic And Nontherapeutic Effe...	5 (1.2%)
Enzyme	4 (.96%)
Leukemias	4 (.96%)
Movement Disorders	4 (.96%)
Appetite And General Nutritional	3 (.72%)
Arteriosclerosis, Stenosis, Vascula...	3 (.72%)
Bile Duct	3 (.72%)
Cardiac Arrhythmias	3 (.72%)
Cardiac Disorder Signs	3 (.72%)
Chemical Injury And Poisoning	3 (.72%)
Tongue Conditions	3 (.72%)
White Blood Cell	3 (.72%)
Cardiac And Vascular Investigations	2 (.48%)
Central Nervous System Vascular	2 (.48%)
Dementia And Amnestic Conditions	2 (.48%)
Electrolyte And Fluid Balance Condi...	2 (.48%)
Fatal Outcomes	2 (.48%)
Gastrointestinal Stenosis And Obstr...	2 (.48%)
Gastrointestinal Ulceration And Per...	2 (.48%)
Hypothalamus And Pituitary Gland	2 (.48%)
Immune	2 (.48%)
Physical Examination Topics	2 (.48%)
Skin Appendage Conditions	2 (.48%)
Vulvovaginal Disorders	2 (.48%)
Cognitive And Attention Disorders	1 (.24%)
Coronary Artery	1 (.24%)
Deliria	1 (.24%)
Disturbances In Thinking	1 (.24%)
Headaches	1 (.24%)
Injuries	1 (.24%)
Inner Ear And Viiith Cranial Nerve	1 (.24%)
Metabolic, Nutritional And Blood Ga...	1 (.24%)
Ocular Infections, Irritations And ...	1 (.24%)
Protein And Chemistry Analyses	1 (.24%)
Psychiatric And Behavioural Symptom...	1 (.24%)
Skin Vascular Abnormalities	1 (.24%)
Toxicology And Therapeutic Drug Mon...	1 (.24%)
Vascular Hemorrhagic	1 (.24%)
Viral Infectious	1 (.24%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zithromac Sr, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromac Sr is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.